- Home
- EFSI vs ENTA Comparison
EFSI vs ENTA Comparison
Compare EFSI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSI
- ENTA
- Stock Information
- Founded
- EFSI 1881
- ENTA 1995
- Country
- EFSI United States
- ENTA United States
- Employees
- EFSI N/A
- ENTA 131
- Industry
- EFSI Major Banks
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- EFSI Finance
- ENTA Health Care
- Exchange
- EFSI Nasdaq
- ENTA Nasdaq
- Market Cap
- EFSI 201.2M
- ENTA 316.2M
- IPO Year
- EFSI N/A
- ENTA 2013
- Fundamental
- Price
- EFSI $36.21
- ENTA $10.96
- Analyst Decision
- EFSI Strong Buy
- ENTA Strong Buy
- Analyst Count
- EFSI 2
- ENTA 5
- Target Price
- EFSI $39.50
- ENTA $21.00
- AVG Volume (30 Days)
- EFSI 9.2K
- ENTA 518.3K
- Earning Date
- EFSI 10-23-2025
- ENTA 11-17-2025
- Dividend Yield
- EFSI 3.42%
- ENTA N/A
- EPS Growth
- EFSI N/A
- ENTA N/A
- EPS
- EFSI 2.13
- ENTA N/A
- Revenue
- EFSI $66,122,000.00
- ENTA $64,806,000.00
- Revenue This Year
- EFSI N/A
- ENTA $0.07
- Revenue Next Year
- EFSI $28.84
- ENTA N/A
- P/E Ratio
- EFSI $16.98
- ENTA N/A
- Revenue Growth
- EFSI 3.18
- ENTA N/A
- 52 Week Low
- EFSI $28.70
- ENTA $4.09
- 52 Week High
- EFSI $40.03
- ENTA $15.34
- Technical
- Relative Strength Index (RSI)
- EFSI 43.62
- ENTA 54.87
- Support Level
- EFSI $36.02
- ENTA $10.30
- Resistance Level
- EFSI $38.94
- ENTA $11.45
- Average True Range (ATR)
- EFSI 0.80
- ENTA 0.62
- MACD
- EFSI -0.07
- ENTA -0.12
- Stochastic Oscillator
- EFSI 23.74
- ENTA 41.67
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.